RADX·75041J101·US·ADR·Healthcare - Biotechnology-13D/G
RADX (Radiopharm Theranostics) is held by 4 institutional investors as of Q1 2026. Largest holders: HSBC HOLDINGS PLC ($264,513), PNC FINANCIAL SERVICES GROUP, INC. ($68,800), UBS Group AG ($12,900). Net institutional sentiment: Bearish.
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer